Share-based Payment Arrangement, Expense of Royalty Pharma plc from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Royalty Pharma plc quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Royalty Pharma plc Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $73,353,000, a 10188% increase year-over-year.
  • Royalty Pharma plc annual Share-based Payment Arrangement, Expense for 2021 was $3,100,000, a 46% decline from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Royalty Pharma plc Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $73,353,000 +$72,640,000 +10188% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $91,044,000 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q3 2024 $713,000 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q1 2022 $2,900,000 $700,000 -$200,000 -22% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $3,100,000 $600,000 01 Oct 2021 31 Dec 2021 10-K 15 Feb 2022 2021 FY
Q3 2021 $700,000 -$300,000 -30% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $900,000 -$2,800,000 -76% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $900,000 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q3 2020 $1,000,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $3,700,000 +$3,700,000 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q2 2019 $0 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2

Royalty Pharma plc Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2021 $3,100,000 -$2,600,000 -46% 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2022 2021 FY
2020 $5,700,000 01 Jan 2020 31 Dec 2020 10-K 15 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.